Clinical Trials Directory

Trials / Completed

CompletedNCT00416000

Mechanism and Prevention of Remote Organ Injury Following Ruptured Aortic Aneurysm

Phase 1 Study of Complement Activation Following Ruptured Abdominal Aortic Aneurysm: Combining Human Observation With Animal Experimentation to Establish a Framework for Human Therapy

Status
Completed
Phase
Study type
Observational
Enrollment
24 (actual)
Sponsor
University Health Network, Toronto · Academic / Other
Sex
All
Age
30 Years – 80 Years
Healthy volunteers
Not accepted

Summary

It has been estimated that 80% of deaths from abdominal aortic aneurysms results from rupture. Endovascular Aneurysm Repair (EVAR) has been applied to RAAA (Ruptured Abdominal Aortic Aneurysm) patients with reports of improvements. Despite the use of EVAR, patients have developed complications with lung and kidney function. This study will investigate certain biochemical processes that will potentially reduce these complications. Knowledge gained from this study may also be used to further research in this field through larger studies.

Conditions

Timeline

Start date
2006-01-01
Primary completion
2010-06-01
Completion
2010-12-01
First posted
2006-12-27
Last updated
2014-05-21

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00416000. Inclusion in this directory is not an endorsement.

Mechanism and Prevention of Remote Organ Injury Following Ruptured Aortic Aneurysm (NCT00416000) · Clinical Trials Directory